Brickell Biotech Stock Z Score
BBIDelisted Stock | USD 1.79 0.34 23.45% |
Brickell |
Brickell Biotech Company Z Score Analysis
Brickell Biotech's Z-Score is a simple linear, multi-factor model that measures the financial health and economic stability of a company. The score is used to predict the probability of a firm going into bankruptcy within next 24 months or two fiscal years from the day stated on the accounting statements used to calculate it. The model uses five fundamental business ratios that are weighted according to algorithm of Professor Edward Altman who developed it in the late 1960s at New York University..
| |||||||
| |||||||
| |||||||
| |||||||
|
To calculate a Z-Score, one would need to know a company's current working capital, its total assets and liabilities, and the amount of its latest earnings as well as earnings before interest and tax. Z-Scores can be used to compare the odds of bankruptcy of companies in a similar line of business or firms operating in the same industry. Companies with Z-Scores above 3.1 are generally considered to be stable and healthy with a low probability of bankruptcy. Scores that fall between 1.8 and 3.1 lie in a so-called 'grey area,' with scores of less than 1 indicating the highest probability of distress. Z Score is a used widely measure by financial auditors, accountants, money managers, loan processors, wealth advisers, and day traders. In the last 25 years, many financial models that utilize z-scores proved it to be successful as a predictor of corporate bankruptcy.
CompetitionIn accordance with the company's disclosures, Brickell Biotech has a Z Score of 0.0. This is 100.0% lower than that of the Biotechnology sector and 100.0% lower than that of the Health Care industry. The z score for all United States stocks is 100.0% higher than that of the company.
Did you try this?
Run Sectors Now
SectorsList of equity sectors categorizing publicly traded companies based on their primary business activities |
All Next | Launch Module |
Brickell Fundamentals
Return On Equity | -1.57 | |||
Return On Asset | -0.8 | |||
Operating Margin | (6.58) % | |||
Current Valuation | (8.35 M) | |||
Shares Outstanding | 2.87 M | |||
Shares Owned By Insiders | 1.20 % | |||
Shares Owned By Institutions | 13.07 % | |||
Number Of Shares Shorted | 189.59 K | |||
Price To Earning | (35.16) X | |||
Price To Book | 0.41 X | |||
Price To Sales | 1.45 X | |||
Revenue | 404 K | |||
Gross Profit | (27.83 M) | |||
EBITDA | (39.38 M) | |||
Net Income | (39.47 M) | |||
Cash And Equivalents | 17.29 M | |||
Cash Per Share | 6.52 X | |||
Total Debt | 69 K | |||
Debt To Equity | 0 % | |||
Current Ratio | 4.36 X | |||
Book Value Per Share | 5.81 X | |||
Cash Flow From Operations | (36.15 M) | |||
Short Ratio | 0.62 X | |||
Earnings Per Share | (0.42) X | |||
Target Price | 17.83 | |||
Number Of Employees | 16 | |||
Beta | 0.0796 | |||
Market Capitalization | 6.75 M | |||
Total Asset | 29.72 M | |||
Retained Earnings | (145.37 M) | |||
Working Capital | 24.79 M | |||
Current Asset | 52.66 M | |||
Current Liabilities | 5.61 M | |||
Net Asset | 29.72 M |
About Brickell Biotech Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Brickell Biotech's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Brickell Biotech using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Brickell Biotech based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics. You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.
Other Consideration for investing in Brickell Stock
If you are still planning to invest in Brickell Biotech check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Brickell Biotech's history and understand the potential risks before investing.
Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
Money Managers Screen money managers from public funds and ETFs managed around the world | |
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
Global Correlations Find global opportunities by holding instruments from different markets | |
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities |